Friday, December 14, 2012

Neglected diseases and mortality

There are concern about the way the medical diseases are perceived and the attention is given to them in terms of detection tests, treatments and  research spending in the recent past. Biomedical progress on neglected diseases seems to be very slow and limited. The neglected diseases account for 2.6 million deaths a year. 756 new drugs are approved for use in Europe and USA and only 3.8.% of them are going to be useful for the neglected diseases. That means these diseases are truly neglected as their name says.

The neglected group of diseases includes malaria, tuberculosis, lethal childhood diarrhoea, and other diseases that kill impoverished people around the world, who tend to lack clean water, secure housing, sanitary waste disposal, and access to healthcare. People who live on less than $2 per day cannot afford high-priced drugs, and therefore drug companies have little incentive to spend millions to develop the drugs and bring them to market.

This is going to be an important issue for many countries to address in the coming years. Prioritisation of the research funding and health care expenditure allocation in the health budgets needs to appropriate to the needs of the society.  Although drugs and vaccines are an essential step in saving the millions who die each year of neglected diseases, public health experts point out that they can only help if they reach the most vulnerable populations. Almost 2 million children under five years old die each year worldwide from diseases which existing vaccines could prevent.
    

No comments: